Manchester University NHS Foundation Trust - Wythenshawe Hospital

The Manchester University NHS Foundation Trust - Wythenshawe Hospital incorporates Wythenshawe Hospital in Manchester https://mft.nhs.uk//
Case Ascertainment for 2018-19 and 2019-20 was calculated for the entire trust.

For 2022-2023 outcomes, Manchester Royal Infirmary, Wythenshawe Hospital and North Manchester General Hospital are reporting under the Manchester University NHS Foundation Trust

View latest outcomes

View Trust Services

This trust offers the following services:

  • Diagnostic and pre-operative services:
    • On-site PET-CT facilities
    • On-site Cardio-Pulmonary Exercise Testing (CPET) facilities
    • Age Specific Genetic Testing for Lynch Syndrome
  • Surgical services:
    • On-site hepatobiliary surgical team
    • On-site thoracic surgical team
    • Robotic surgery
  • Advanced disease services:
    • Dedicated Specialist Advanced MDT
    • Complex vascular reconstruction
    • Extended lymphadenectomy
  • Support service facilities:
    • Dedicated nurses for ERAS services
    • 7-day access to face-to-face palliative care services

Data Quality
All Patients: Trust Network National
Number of patients in Audit 144 1862 35779
Case ascertainment (%) Good Good Good
Data completeness of:
– Pre-treatment TNM (%) 79 87 86
– Performance status (%) 98 89 89
Patients having major resection: Trust Network National
Number of patients in Audit 110 994 19631
ASA grade 1 (%) 6 16 9
ASA grade 2 (%) 43 44 53
ASA grade 3 (%) 46 36 31
ASA grade 4+ (%) 4 2 2
ASA grade not recorded (%) 1 2 4
Data completeness of:
7 Audit items for risk-adjustment (%) 98 95 87

Key:

> 80%
50 - 80%
< 50%

Management of all patients
All Patients: Trust Network National
Number of patients in Audit 144 1862 35779
Seen by Clinical Nurse Specialist (%) 99 92 88

Management of patients having major resection
Patients having major resection: Trust Network National
Number of patients in Audit 110 994 19614
Distant metastases (%) 3 4 5
Urgent or emergency surgery (%) 11 12 15
At least 12 lymph nodes excised (%) 97 89 84
Laparoscopic surgery attempted (%) 64 63 72
Risk-adjusted length of stay > 5 days (%) 47 60 55
Patients having major resection for stage III colon cancer: Trust Network National
Number of patients in audit 70 N/A 10747
Adjuvant chemotherapy (%) 56 N/A 62
Patients receiving chemotherapy after major resection for stage III colon cancer: Trust Network National
Number of patients in audit N/A N/A 6608
Severe acute toxicity after adjuvant chemotherapy (%) N/A N/A 22

Rectal cancer patients
Patients having major resection: Trust Network National
Number of patients in Audit 26 N/A 4251
Neoadjuvant therapy (%) 18 N/A 33
Circumferential resection margin: Recorded (%) 96 96 89
Circumferential resection margin: Negative (%) 96 89 83
Rectal volume 22 N/A 4377
Patients in APER/Hartmanns estimate: Trust Network National
Number of patients in APER/Hartmanns estimate 95 809 19644
APER/Hartmanns (%) 42 43 37

Compare trust outcomes

Copyright © 2025 National Bowel Cancer Audit | Lovingly Crafted by Mixd